Sources of off-target effects of vagus nerve stimulation using the helical clinical lead in domestic pigs
Open Access
- 23 July 2020
- journal article
- research article
- Published by IOP Publishing in Journal of Neural Engineering
- Vol. 17 (4) , 046017
Abstract
Objective: Clinical data suggest that efficacious vagus nerve stimulation (VNS) is limited by side effects such as cough and dyspnea that have stimulation thresholds lower than those for therapeutic outcomes. VNS side effects are putatively caused by activation of nearby muscles within the neck, via direct muscle activation or activation of nerve fibers innervating those muscles. Our goal was to determine the thresholds at which various VNS-evoked effects occur in the domestic pig—an animal model with vagus anatomy similar to human—using the bipolar helical lead deployed clinically. Approach: Intrafascicular electrodes were placed within the vagus nerve to record electroneurographic (ENG) responses, and needle electrodes were placed in the vagal-innervated neck muscles to record electromyographic (EMG) responses. Main results: Contraction of the cricoarytenoid muscle occurred at low amplitudes (∼0.3 mA) and resulted from activation of motor nerve fibers in the cervical vagus trunk within the electrode cuff which bifurcate into the recurrent laryngeal branch of the vagus. At higher amplitudes (∼1.4 mA), contraction of the cricoarytenoid and cricothyroid muscles was generated by current leakage outside the cuff to activate motor nerve fibers running within the nearby superior laryngeal branch of the vagus. Activation of these muscles generated artifacts in the ENG recordings that may be mistaken for compound action potentials representing slowly conducting Aδ-, B-, and C-fibers. Significance: Our data resolve conflicting reports of the stimulation amplitudes required for C-fiber activation in large animal studies (>10 mA) and human studies (μA). After removing muscle-generated artifacts, ENG signals with post-stimulus latencies consistent with Aδ- and B-fibers occurred in only a small subset of animals, and these signals had similar thresholds to those that caused bradycardia. By identifying specific neuroanatomical pathways that cause off-target effects and characterizing the stimulation dose-response curves for on- and off-target effects, we hope to guide interpretation and optimization of clinical VNS.Keywords
All Related Versions
Funding Information
- Defense Advanced Research Projects Agency (SPAWAR SSC N66001-17-2-4010)
- National Center for Advancing Translational Sciences (CTSA TL1 TR002380)
- Office of Strategic Coordination (SPARC OT2 OD025340)
This publication has 58 references indexed in Scilit:
- Muscle afferent activation causes ventilatory and cardiovascular responses during concurrent hypercapnia in humansExperimental Physiology, 2012
- Recruitment and blocking properties of the CardioFit stimulation leadJournal of Neural Engineering, 2011
- Isoflurane Inhibits the Neurotransmitter Release MachineryJournal of Neurophysiology, 2009
- A comparative study of three techniques for diameter selective fiber activation in the vagal nerve: anodal block, depolarizing prepulses and slowly rising pulsesJournal of Neural Engineering, 2008
- Intraoperative human vagus nerve compound action potentialsActa Neurologica Scandinavica, 2004
- Baroreceptor control of central and regional hemodynamics with isoflurane in the dogActa Anaesthesiologica Scandinavica, 1988
- Baroreceptor Reflex Control of Heart Rate during Isoflurane Anesthesia in HumansAnesthesiology, 1984
- Effects of Isoflurane on the Baroreceptor ReflexAnesthesiology, 1983
- Central sites and mechanisms of the hypotensive and bradycardic effects of the narcotic analgesic agent fentanylNaunyn-Schmiedeberg's Archives of Pharmacology, 1977
- The numbers of nerve fibers in the vagus nerve of manThe Anatomical Record, 1961